We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$89.6B
AUM Growth
-$307M
(-0.34%)
Cap. Flow
-$521M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
13.13%
Holding
1,015
New
93
Increased
423
Reduced
329
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$536M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
+$409M |
| 3 |
PepsiCo
PEP
|
+$325M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$220M |
| 5 |
PG&E
PCG
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras Class A
PBR.A
|
+$417M |
| 2 |
WPZ
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
|
+$383M |
| 3 |
AGN
Allergan Inc
AGN
|
+$340M |
| 4 |
AbbVie
ABBV
|
+$257M |
| 5 |
Exelon
EXC
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.02% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 12.41% |
| 4 | Communication Services | 11.87% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Merck
MRK
$324B
| $312M | 0.35% |
5,685,958
-60,151
| -1% | -$3.41M |
|
|
OKS
77
DELISTED
Oneok Partners LP
OKS
| $312M | 0.35% |
7,633,296
+191,680
| +3% | +$8.01M |
|
78
Microsoft
MSFT
$2.84T
| $311M | 0.35% |
7,645,048
+643,643
| +9% | +$28M |
|
79
CVS Health
CVS
$137B
| $308M | 0.34% |
2,984,650
-227,110
| -7% | -$23M |
|
80
HCA Healthcare
HCA
$84.8B
| $307M | 0.34% |
4,082,445
+452,802
| +12% | +$32.5M |
|
81
Philip Morris
PM
$301B
| $305M | 0.34% |
4,044,011
-726,344
| -15% | -$59M |
|
82
GE Aerospace
GE
$367B
| $302M | 0.34% |
2,543,097
-1,381,065
| -35% | -$164M |
|
83
Amdocs
DOX
$5.53B
| $302M | 0.34% |
5,544,980
+227,175
| +4% | +$11.5M |
|
84
Vulcan Materials
VMC
$36.3B
| $294M | 0.33% |
3,483,124
-797,818
| -19% | -$61.6M |
|
|
DCP
85
DELISTED
DCP Midstream, LP
DCP
| $292M | 0.33% |
7,891,892
-201,231
| -2% | -$7.94M |
|
|
TGP
86
DELISTED
Teekay LNG Partners L.P.
TGP
| $288M | 0.32% |
7,697,775
+322,615
| +4% | +$12.2M |
|
87
Genesis Energy
GEL
$1.84B
| $287M | 0.32% |
6,100,101
+838,326
| +16% | +$37.3M |
|
88
Nektar Therapeutics
NKTR
$2.39B
| $286M | 0.32% |
1,733,333
+120,000
| +7% | +$24.7M |
|
|
EQM
89
DELISTED
EQM Midstream Partners, LP
EQM
| $285M | 0.32% |
3,664,513
+62,492
| +2% | +$5.14M |
|
90
3M
MMM
$89B
| $284M | 0.32% |
2,062,079
+2,823
| +0.1% | +$389K |
|
|
LNKD
91
DELISTED
LinkedIn Corporation
LNKD
| $280M | 0.31% |
1,121,085
+62,980
| +6% | +$15.6M |
|
|
TWX
92
DELISTED
Time Warner Inc
TWX
| $277M | 0.31% |
3,280,482
-117,637
| -3% | -$9.77M |
|
93
NGL Energy Partners
NGL
$1.94B
| $274M | 0.31% |
10,462,664
+157,829
| +2% | +$4.46M |
|
94
Visa
V
$677B
| $274M | 0.31% |
4,195,496
-355,920
| -8% | -$23.5M |
|
95
VF Corp
VFC
$6.68B
| $268M | 0.3% |
3,777,152
-484,229
| -11% | -$33.5M |
|
96
TJX Companies
TJX
$170B
| $265M | 0.3% |
7,551,836
-2,998,164
| -28% | -$102M |
|
97
Cisco
CSCO
$450B
| $261M | 0.29% |
9,499,342
+387,330
| +4% | +$10.9M |
|
|
QUNR
98
DELISTED
Qunar Cayman Islands Limited
QUNR
| $261M | 0.29% |
6,325,400
+726,300
| +13% | +$22.1M |
|
|
ANDX
99
DELISTED
Andeavor Logistics LP
ANDX
| $258M | 0.29% |
4,791,878
+2,817
| +0.1% | +$155K |
|
100
Celldex Therapeutics
CLDX
$2.77B
| $254M | 0.28% |
608,344
-11,861
| -2% | -$4.24M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2015 Portfolio in Review
As of Q1 2015, OppenheimerFunds held 1,015 positions worth $89.6B, down 0.34% from $89.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
OppenheimerFunds's Q1 2015 filing shows 93 new, 423 increased, 329 reduced and 118 closed positions. Its largest new stake was UBS Group: 30,806,912 shares worth $578M. The largest sale was Petrobras Class A, an estimated $417M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q1 2015 buy was UBS Group: 30,806,912 shares worth $578M.
- OppenheimerFunds added most to Williams Partners L.P. in Q1 2015, an estimated $409M increase.
- OppenheimerFunds's biggest Q1 2015 reduction was AbbVie, cutting an estimated $257M.
- OppenheimerFunds fully exited Petrobras Class A in Q1 2015, selling an estimated $417M.
- OppenheimerFunds's ten largest holdings make up 13% of its $89.6B portfolio in Q1 2015.
- OppenheimerFunds opened 93 new positions and closed 118 in Q1 2015.
- OppenheimerFunds's portfolio value fell 0.34% quarter-over-quarter to $89.6B.
Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.